Suppr超能文献

利钠作用与钠钾ATP酶的抑制:通过生理操作对反应的调节

Natriuresis and inhibition of Na+/K(+)-ATPase: modulation of response by physiological manipulation.

作者信息

McDougall J G, Yates N A

机构信息

Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, Victoria, Australia.

出版信息

Clin Exp Pharmacol Physiol Suppl. 1998 Nov;25:S57-60. doi: 10.1111/j.1440-1681.1998.tb02302.x.

Abstract
  1. There is considerable evidence for the existence of an endogenous inhibitor of Na+/K(+)-ATPase. The exact physiological nature and role of this postulated agent remains unclear, although it would be predicted that one of its actions would be stimulation of renal sodium excretion. 2. The natriuretic effect of renal arterial infusion of ouabain is relatively slow in onset and is sustained. 3. The natriuresis is not modified by changes in sodium status, unlike the natriuretic effect of atrial natriuretic peptide. 4. The natriuretic action of ouabain is enhanced dramatically by acute volume expansion or chronic mineralocorticoid treatment, which both result in hypokalaemia, hypertension and hypervolaemia. 5. The natriuretic response to small increments in blood pressure is markedly enhanced by treatment with ouabain. 6. We hypothesize that the interaction between the inhibition of Na+/K(+)-ATPase and elevated blood pressure could result in the shedding of sodium in conditions where there are increased levels of circulating endogenous digitalis-like factors.
摘要
  1. 有大量证据表明存在一种Na+/K(+)-ATP酶的内源性抑制剂。尽管据推测其作用之一是刺激肾钠排泄,但这种假定物质的确切生理性质和作用仍不清楚。2. 肾动脉注入哇巴因的利钠效应起效相对缓慢且持续存在。3. 与心房利钠肽的利钠效应不同,钠状态的改变不会改变这种利钠作用。4. 急性容量扩张或慢性盐皮质激素治疗均可显著增强哇巴因的利钠作用,这两种情况都会导致低钾血症、高血压和血容量过多。5. 哇巴因治疗可显著增强对血压小幅升高的利钠反应。6. 我们推测,在循环中内源性类洋地黄因子水平升高的情况下,抑制Na+/K(+)-ATP酶与血压升高之间的相互作用可能导致钠的排出。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验